Zhi-bin Liu Selected Research

2,2',2''-trichlorotriethylamine (HN 3)

4/2011	[Effect of "Xiusanzhen" on hippocampal muscarinic cholinergic receptor activity in Alzheimer disease rats].
2/2011	[Effect of "Xiusanzhen"on expression of hippocampal Bcl-2 and Bax proteins in Alzheimer disease rats].
2/2009	[Effect of "Xiusanzhen" on learning-memory ability and hippocampal ChAT and AChE activity in Alzheimer disease rats].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhi-bin Liu Research Topics

Disease

3	Alzheimer Disease (Alzheimer's Disease) 04/2011 - 02/2009
2	Tuberculosis (Tuberculoses) 12/2011 - 03/2011
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 04/2008 - 06/2007
1	Anemia 05/2014
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2012
1	Fever (Fevers) 12/2011
1	Hemoptysis 12/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2011
1	Leukemia 02/2011
1	Dementia (Dementias) 06/2007
1	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2005

Drug/Important Bio-Agent (IBA)

3	2,2',2''-trichlorotriethylamine (HN 3)IBA 04/2011 - 02/2009
2	Therapeutic UsesIBA 07/2012 - 06/2007
1	Cholinergic Agents (Cholinergics)IBA 04/2011
1	Cholinergic ReceptorsIBA 04/2011
1	Pharmaceutical PreparationsIBA 03/2011
1	Proteins (Proteins, Gene)FDA Link 02/2011
1	TransferasesIBA 02/2009
1	Choline (Choline Chloride)IBA 02/2009
1	Cholinesterases (Cholinesterase)IBA 02/2009
1	N-formyl-13-dihydrocarminomycin (NFD)IBA 06/2007
1	Biomarkers (Surrogate Marker)IBA 11/2005

Therapy/Procedure

3	Therapeutics 05/2014 - 06/2007
3	Electroacupuncture 04/2011 - 04/2008
1	Retreatment 12/2011
1	Acupuncture Points (Acupuncture Point) 02/2011
1	Aftercare (After-Treatment) 06/2007